Investigating The Role Of The Human Naip/nlrc4 Inflammasome In Host Defense Against Gram-Negative Bacterial Infection
Degree type
Graduate group
Discipline
Subject
flagellin
inflammasome
NAIP
NLRC4
type III secretion system
Allergy and Immunology
Cell Biology
Immunology and Infectious Disease
Medical Immunology
Microbiology
Funder
Grant number
License
Copyright date
Distributor
Related resources
Author
Contributor
Abstract
Inflammasomes are key multiprotein intracellular complexes that mediate host defense against pathogenic microorganisms by activating caspase-1-dependent cytokine secretion and cell death. In mice, specific nucleotide-binding domain, leucine-rich repeat-containing family, apoptosis inhibitory proteins (NAIPs) sense components of the type III secretion system (T3SS) and flagellar apparatus. Upon sensing of bacterial components, NAIPs recruit the nucleotide-binding domain, leucine-rich repeat-containing family, CARD domain-containing protein 4 (NLRC4). The resulting NAIP/NLRC4 inflammasome then recruits and activates caspase-1. Active caspase-1 mediates processing and secretion of IL-1 family cytokines and a proinflammatory cell death termed pyroptosis. In mice, bacterial ligands for four of seven distinct NAIPs are known: NAIP1 recognizes the T3SS needle protein, NAIP2 recognizes the T3SS inner rod protein, and both NAIP5 and NAIP6 recognize flagellin. In contrast, humans encode a single functional NAIP, raising the question of whether human NAIP senses one or multiple bacterial ligands. In this dissertation we show that, in contrast to murine NAIPs, promiscuous recognition of multiple bacterial ligands is conferred by a single human NAIP. We found that NAIP, but not NLRC4, appears to dictate the specificity or promiscuity of bacterial ligand recognition. In addition, our studies define a role for human NAIP in the inflammasome response to Salmonella Typhimurium infection. Overall, we provide a basis for understanding the mechanisms underlying human-specific innate immune responses against gram-negative bacterial infections.